ArticlePeerJ2026
Establishment of a prediction model for malignant probability of pulmonary nodules in an adenocarcinoma-predominant cohort.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to identify associated factors for malignancy in pulmonary nodules and establish a risk prediction model to provide a scientific basis for surgical decision-making. Methods: Patients with pulmonary nodules who underwent surgical resection were retrospectively enrolled for this study. Demographic data, tumor marker levels, computed tomography (CT) features, and pathological results were collected. Univariate and multivariate analyses were performed to identify independent associated factors and construct a predictive model. The model's performance was evaluated using the receiver operating characteristic (ROC) curve. Results: A total of 568 patients were included, comprising 146 benign and 422 malignant nodules. The vast majority of malignant nodules were lung adenocarcinomas ( Conclusion: In this adenocarcinoma-predominant cohort, female sex was a significant predictor of malignancy, suggesting that non-smoking women may benefit from increased attention in lung cancer screening strategies. Further validation in diverse populations is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.